Nothing Special   »   [go: up one dir, main page]

FI50059C - Menetelmä hidasvaikutteisten tablettien kaltaisten annostusyksikköjen valmistamiseksi. - Google Patents

Menetelmä hidasvaikutteisten tablettien kaltaisten annostusyksikköjen valmistamiseksi.

Info

Publication number
FI50059C
FI50059C FI691784A FI178469A FI50059C FI 50059 C FI50059 C FI 50059C FI 691784 A FI691784 A FI 691784A FI 178469 A FI178469 A FI 178469A FI 50059 C FI50059 C FI 50059C
Authority
FI
Finland
Prior art keywords
tablet
preparation
dosage units
delayed action
delayed
Prior art date
Application number
FI691784A
Other languages
English (en)
Swedish (sv)
Other versions
FI50059B (fi
Inventor
Karl Gunnar Eriksson
Arnold Mangen
Original Assignee
Karl Gunnar Eriksson
Arnold Mangen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Gunnar Eriksson, Arnold Mangen filed Critical Karl Gunnar Eriksson
Application granted granted Critical
Publication of FI50059B publication Critical patent/FI50059B/fi
Publication of FI50059C publication Critical patent/FI50059C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
FI691784A 1968-06-19 1969-06-16 Menetelmä hidasvaikutteisten tablettien kaltaisten annostusyksikköjen valmistamiseksi. FI50059C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE08362/68A SE335202B (fi) 1968-06-19 1968-06-19

Publications (2)

Publication Number Publication Date
FI50059B FI50059B (fi) 1975-09-01
FI50059C true FI50059C (fi) 1975-12-10

Family

ID=20273866

Family Applications (1)

Application Number Title Priority Date Filing Date
FI691784A FI50059C (fi) 1968-06-19 1969-06-16 Menetelmä hidasvaikutteisten tablettien kaltaisten annostusyksikköjen valmistamiseksi.

Country Status (12)

Country Link
US (1) US3670065A (fi)
AT (1) AT287205B (fi)
BE (1) BE734847A (fi)
CA (1) CA933468A (fi)
DE (1) DE1948019C3 (fi)
FI (1) FI50059C (fi)
FR (1) FR2011960A1 (fi)
GB (1) GB1272640A (fi)
HU (1) HU168386B (fi)
NL (1) NL6808619A (fi)
NO (1) NO129381B (fi)
SE (1) SE335202B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
NL7314765A (fi) * 1972-10-31 1974-05-02
SE375007B (fi) * 1972-11-30 1975-04-07 Pharmacia Ab
US3968201A (en) * 1972-11-30 1976-07-06 Pharmacia Aktiebolag Dosage unit containing a substance showing a topical effect on the eye, and a method of preparing same
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3610878A1 (de) * 1986-04-01 1987-10-08 Boehringer Ingelheim Kg Formlinge aus pellets
US5290569A (en) * 1990-04-12 1994-03-01 Shionogi & Co., Ltd. Coated composition and its preparation process
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US6743756B2 (en) * 2001-01-26 2004-06-01 Benchmark Research And Technology, Inc. Suspensions of particles in non-aqueous solvents
DE60239945D1 (de) 2001-09-28 2011-06-16 Mcneil Ppc Inc Darreichungsformen zur modifizierten freisetzung
US20040259809A1 (en) * 2003-06-17 2004-12-23 Pediamed Pharmaceuticals, Inc. Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof
DE102004002732B4 (de) * 2004-01-20 2006-11-16 Dr. Paul Lohmann Gmbh Kg Herstellungsverfahren für mikroverkapselte Eisen-II-Sulfat enthaltende Partikel sowie Eisen-II-Sulfat enthaltende Partikel mit Mikroverkapselungen
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
BRPI0819231B8 (pt) * 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
US20110070301A1 (en) 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
BR112016015944A8 (pt) 2014-01-10 2020-06-09 Johnson & Johnson Consumer Inc processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061510A (en) * 1958-08-01 1962-10-30 Olin Mathieson Radioactive iodinated (i131) fatty material admixed with wax-like material in capsule
NL269886A (fi) * 1960-10-04
US3297804A (en) * 1964-05-19 1967-01-10 Ono Pharmaceutical Co Method of filling hard capsules with granules by the open-mouth-down punching method
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation

Also Published As

Publication number Publication date
GB1272640A (en) 1972-05-03
SE335202B (fi) 1971-05-17
FR2011960A1 (fi) 1970-03-13
CA933468A (en) 1973-09-11
HU168386B (fi) 1976-04-28
DE1948019A1 (de) 1971-03-25
BE734847A (fi) 1969-12-01
DE1948019B2 (de) 1975-10-16
AT287205B (de) 1971-01-11
NO129381B (fi) 1974-04-08
DE1948019C3 (de) 1979-06-13
NL6808619A (fi) 1969-12-23
US3670065A (en) 1972-06-13
FI50059B (fi) 1975-09-01

Similar Documents

Publication Publication Date Title
FI50059C (fi) Menetelmä hidasvaikutteisten tablettien kaltaisten annostusyksikköjen valmistamiseksi.
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI51347C (fi) Menetelmä 1-substituoitujen-3- ja -4-aroyylipiperidiinien valmistamise ksi.
FI51046C (fi) Menetelmä asetosalisyylihappotabletin valmistamiseksi.
DK127923B (da) Fremgangsmåde til fremstilling af maltitol.
FI48062C (fi) Menetelmä ksylitolin valmistamiseksi
FI48344C (fi) Menetelmä limaa hajoittavien N-asyyli-kysteiiniamidien valmistamiseksi .
FI47572C (fi) Menetelmä 19-norandrost-4-eeni-3,17-dionien valmistamiseksi.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI48463C (fi) Menetelmä veren sokerpitoisuutta alentavien bentsolisulfonyyli-virtsa- aineiden valmistamiseksi.
FI47575C (fi) Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi.
FI52216C (fi) Menetelmä gamma-piperidinobutyrofenonijohdannaisten valmistamiseksi.
FI51587C (fi) Menetelmä terapeuttisesti vaikuttavien sulfamyyli-m-aminobentsoehappoj en valmistamiseksi.
FI45963C (fi) Menetelmä veren sokeripitoisuutta alentavien bentseenisulfonyylivirtsa -aineiden valmistamiseksi.
FI49407C (fi) Menetelmä kokkidiostaattisen vaikutuksen omaavien kinoliinikarbonihapp oestereiden valmistamiseksi.
FI50407C (fi) Menetelmä trikloorimonosilaanien valmistamiseksi
FI45957C (fi) Menetelmä veren sokeripitoisuutta alentavien bentseenisulfonyylivirtsa -aineiden valmistamiseksi.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI45964C (fi) Menetelmä veren sokeripitoisuutta alentavien bentsolisulfonyylivirtsa- aineiden valmistamiseksi.
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
FI47576C (fi) Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi.
FI48347C (fi) Menetelmä 17beta-alkanoyylioksi-17alfa-propadienyyli-steroidien valmis tamiseksi.
FI51814C (fi) Menetelmä alfa-karboksibentsyylipenisiliinin kielteisen alkalimetallis uolojen valmistamiseksi.
FR2019292A2 (fr) Procede de preparation de polyacyloxamidrazones
FI52088C (fi) Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi.